Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): ...
| Image |  |
|---|---|
| Description | scientific article (publication date: December 2015) |
| Author/s |
author: Eva M Ciruelos Thomas Bachelot Pirkko-Liisa Kellokumpu-Lehtinen Heikki Joensuu Federico Piacentini Petri Bono |
| Publication date | December 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |